348 related articles for article (PubMed ID: 31094036)
1. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
[TBL] [Abstract][Full Text] [Related]
2. Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor.
Sprenger FS; Wurster I; Seppi K; Stockner H; Scherfler C; Sojer M; Schmidauer C; Berg D; Poewe W
Mov Disord; 2016 Apr; 31(4):579-83. PubMed ID: 26893155
[TBL] [Abstract][Full Text] [Related]
3. Differentiating Parkinson's Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis.
Heim B; Peball M; Hammermeister J; Djamshidian A; Krismer F; Seppi K
J Parkinsons Dis; 2022; 12(4):1115-1123. PubMed ID: 35180133
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.
López Hernández N; García Escrivá A; Shalabi Benavent M
Neurologia; 2015 Oct; 30(8):496-501. PubMed ID: 24839905
[TBL] [Abstract][Full Text] [Related]
5. [Transcranial sonography (TCS) in evaluation of patients with essential tremor].
Budisić M; Trkanjec Z; Lovrencić-Huzjan A; Supanc V; Vuković V; Demarin V
Acta Med Croatica; 2009 Dec; 63 Suppl 3():51-4. PubMed ID: 20232670
[TBL] [Abstract][Full Text] [Related]
6. Midbrain sonography in patients with essential tremor.
Stockner H; Sojer M; K KS; Mueller J; Wenning GK; Schmidauer C; Poewe W
Mov Disord; 2007 Feb; 22(3):414-7. PubMed ID: 17226854
[TBL] [Abstract][Full Text] [Related]
7. Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes.
Laučkaitė K; Rastenytė D; Šurkienė D; Vaitkus A; Sakalauskas A; Lukoševičius A; Gleiznienė R
BMC Neurol; 2012 Mar; 12():12. PubMed ID: 22400906
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing Parkinson's disease and essential tremor with transcranial sonography.
Budisic M; Trkanjec Z; Bosnjak J; Lovrencic-Huzjan A; Vukovic V; Demarin V
Acta Neurol Scand; 2009 Jan; 119(1):17-21. PubMed ID: 18549415
[TBL] [Abstract][Full Text] [Related]
9. Transcranial sonography (TCS) in Parkinson's disease (PD) and essential tremor (ET) in relation with putative premotor symptoms of PD.
Kim JS; Oh YS; Kim YI; Koo JS; Yang DW; Lee KS
Arch Gerontol Geriatr; 2012; 54(3):e436-9. PubMed ID: 22277379
[TBL] [Abstract][Full Text] [Related]
10. Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.
Shafieesabet A; Fereshtehnejad SM; Shafieesabet A; Delbari A; Baradaran HR; Postuma RB; Lökk J
Parkinsonism Relat Disord; 2017 Sep; 42():1-11. PubMed ID: 28647434
[TBL] [Abstract][Full Text] [Related]
11. Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential Tremor.
Richter D; Woitalla D; Muhlack S; Gold R; Tönges L; Krogias C
J Neuroimaging; 2017 Sep; 27(5):524-530. PubMed ID: 28426143
[TBL] [Abstract][Full Text] [Related]
12. Transcranial sonography in essential tremor.
Stockner H; Wurster I
Int Rev Neurobiol; 2010; 90():189-97. PubMed ID: 20692503
[TBL] [Abstract][Full Text] [Related]
13. Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.
Bártová P; Kraft O; Bernátek J; Havel M; Ressner P; Langová K; Herzig R; Skoloudík D
Ultrasound Med Biol; 2014 Oct; 40(10):2365-71. PubMed ID: 25194454
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonographic (TCS) and clinical findings in overlapping phenotype of essential tremor and Parkinson's disease (ET-PD).
Laučkaitė K; Rastenytė D; Šurkienė D; Vaidelytė B; Dambrauskaitė G; Sakalauskas A; Vaitkus A; Gleiznienė R
BMC Neurol; 2014 Mar; 14():54. PubMed ID: 24655437
[TBL] [Abstract][Full Text] [Related]
15. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
[TBL] [Abstract][Full Text] [Related]
16. Essential tremor vs idiopathic Parkinson disease: Utility of transcranial sonography.
Tao A; Chen G; Mao Z; Gao H; Deng Y; Xu R
Medicine (Baltimore); 2020 May; 99(20):e20028. PubMed ID: 32443307
[TBL] [Abstract][Full Text] [Related]
17. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
[TBL] [Abstract][Full Text] [Related]
18. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.
Busse K; Heilmann R; Kleinschmidt S; Abu-Mugheisib M; Höppner J; Wunderlich C; Gemende I; Kaulitz L; Wolters A; Benecke R; Walter U
J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):441-7. PubMed ID: 22362921
[TBL] [Abstract][Full Text] [Related]
19. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations.
Okawa M; Miwa H; Kajimoto Y; Hama K; Morita S; Nakanishi I; Kondo T
Intern Med; 2007; 46(18):1527-31. PubMed ID: 17878638
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
